The alternative splicing event of MZB1 is a potential biomarker of drug resistance in endocrine therapy of breast cancer
ZHANG Yuqing, JING Jing, LIU Zhaoliang, AN Jing, AN Weiwei
Journal of Practical Oncology . 2024, (5): 313 -322 .  DOI: 10.11904/j.issn.1002-3070.2024.05.006